267961000202108: Sitagliptin hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Peptide hydrolase inhibitor\Dipeptidyl peptidase IV inhibitor\Sitagliptin hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Sitagliptin hydrochloride

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Substance with triazole structure (substance)\Sitagliptin hydrochloride
\Organic compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\Sitagliptin hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Dec 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5289351016 Sitagliptin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

5289352011 Sitagliptin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Sitagliptin hydrochloride	Is a	Substance with triazole structure (substance)	true	Inferred relationship	Some
Sitagliptin hydrochloride	Is a	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Some
Sitagliptin hydrochloride	Is a	Serine proteinase inhibitor	false	Inferred relationship	Some
Sitagliptin hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Serine proteinase inhibitor (disposition)	false	Inferred relationship	Some
Sitagliptin hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Some
Sitagliptin hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Sitagliptin (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sitagliptin hydrochloride	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sitagliptin hydrochloride	Inferred relationship	Some	2
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sitagliptin hydrochloride	Inferred relationship	Some	1
Sitagliptin (as sitagliptin hydrochloride) 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sitagliptin hydrochloride	Inferred relationship	Some	1
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Sitagliptin hydrochloride	Inferred relationship	Some	1
Sitagliptin hydrochloride monohydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Sitagliptin hydrochloride	Inferred relationship	Some

This concept is not in any reference sets